| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |